News

Filter

Current filters:

GenmabDuoBody

Genmab reports nine month interim results, including $31 million revenue increase on 2013

Genmab reports nine month interim results, including $31 million revenue increase on 2013

06-11-2014

Danish biotech company Genmab has reported its nine-month interim results, including an increase in revenue…

BiotechnologydaratumumabDenmarkDuoBodyFinancialGenmabOfatumumab Injection

Genmab in collaboration with Janssen for DuoBody platform

16-07-2012

Denmark-based Genmab A/S (OMX: GEN) says it has entered into a collaboration with Janssen Biotech, a…

BiotechnologyDuoBodyGenmabJanssen BiotechJohnson & JohnsonLicensingNovartisPharmaceutical

COMPANY SPOTLIGHT

Menarini

Back to top